Dexamethasone implant in retinal vein occlusions.
作者信息
Han Sang Beom, Kim Moosang, Lee Seung-Jun
机构信息
Department of Ophthalmology, School of Medicine, Kangwon National University, Chuncheon, South Korea.
出版信息
Clin Ophthalmol. 2016 Aug 22;10:1585-6. doi: 10.2147/OPTH.S118028. eCollection 2016.
Abstract
摘要
相似文献
1
Dexamethasone implant in retinal vein occlusions.视网膜静脉阻塞中的地塞米松植入物
Clin Ophthalmol. 2016 Aug 22;10:1585-6. doi: 10.2147/OPTH.S118028. eCollection 2016.
2
Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.玻璃体内注射地塞米松植入物用于临床治疗视网膜静脉阻塞后的黄斑水肿。
Klin Monbl Augenheilkd. 2013 Apr;230(4):423-6. doi: 10.1055/s-0032-1328388. Epub 2013 Apr 29.
3
Aqueous Flare as an Indicator of Response to Dexamethasone Treatment in Retinal Vein Occlusions: A Pilot Study.房水闪光作为视网膜静脉阻塞中地塞米松治疗反应的指标：一项初步研究。
Curr Eye Res. 2016 May;41(5):700-7. doi: 10.3109/02713683.2015.1050740. Epub 2015 Aug 3.
4
[Clinical efficacy of dexamethasone intravitreal implant (Ozurdex) in patients with retinal vein occlusions].地塞米松玻璃体内植入物（Ozurdex）治疗视网膜静脉阻塞患者的临床疗效
Vestn Oftalmol. 2014 May-Jun;130(3):49-53.
5
The impact of intravitreal dexamethasone implant (Ozurdex®) on retrobulbar hemodynamics in patients with diabetic macular edema and retinal vein occlusions.玻璃体内地塞米松植入物（Ozurdex®）对糖尿病性黄斑水肿和视网膜静脉阻塞患者球后血流动力学的影响。
Cutan Ocul Toxicol. 2019 Sep;38(3):240-248. doi: 10.1080/15569527.2019.1582061. Epub 2019 Mar 13.
6
DEXAMETHASONE IMPLANT FOR MACULAR EDEMA SECONDARY TO ISCHEMIC RETINAL VEIN OCCLUSIONS.用于治疗缺血性视网膜静脉阻塞继发黄斑水肿的地塞米松植入剂
Retina. 2015 Jul;35(7):1387-92. doi: 10.1097/IAE.0000000000000492.
7
Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes.雷珠单抗与地塞米松植入物治疗视网膜分支静脉阻塞继发黄斑水肿的两年疗效
Optom Vis Sci. 2018 Dec;95(12):1149-1154. doi: 10.1097/OPX.0000000000001306.
8
Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.玻璃体内注射贝伐单抗后再行地塞米松植入与地塞米松植入单药治疗视网膜静脉阻塞伴黄斑水肿的比较。
Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732. Epub 2012 Jun 23.
9
[Efficacy of intravitreal dexamethasone implants in macular edema excluding venous occlusions: results for a cohort of 80 patients].玻璃体内注射地塞米松植入物治疗非静脉阻塞性黄斑水肿的疗效：80例患者队列研究结果
J Fr Ophtalmol. 2015 Feb;38(2):126-33. doi: 10.1016/j.jfo.2014.08.003. Epub 2015 Jan 13.
10
The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.年龄和初始中心视网膜厚度对视网膜静脉阻塞所致黄斑水肿早期重复使用Ozurdex治疗需求的影响：一项回顾性病例系列研究
J Ocul Pharmacol Ther. 2017 Dec;33(10):763-772. doi: 10.1089/jop.2017.0070. Epub 2017 Sep 26.
本文引用的文献
1
Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy.地塞米松植入物在抗VEGF治疗抵抗的视网膜静脉阻塞中的治疗效果。
Clin Ophthalmol. 2016 May 25;10:947-54. doi: 10.2147/OPTH.S105412. eCollection 2016.
2
Effect of intravitreal injection of dexamethasone 0.7 mg (Ozurdex®) on intraocular pressure in patients with macular edema.玻璃体内注射0.7毫克地塞米松（Ozurdex®）对黄斑水肿患者眼压的影响。
Ophthalmic Res. 2015;54(3):143-9. doi: 10.1159/000438759. Epub 2015 Sep 23.
3
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.地塞米松玻璃体内植入物治疗与分支或中央视网膜静脉阻塞相关的黄斑水肿患者的 12 个月研究结果。
Ophthalmology. 2011 Dec;118(12):2453-60. doi: 10.1016/j.ophtha.2011.05.014. Epub 2011 Jul 20.
Zotero 插件